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Melioidosis is a severe infectious disease caused by the saprophytic facultative intracellular pathogen
Burkholderia pseudomallei. The disease is endemic in Southeast Asia and Northern Australia, and no effective
vaccine exists. To describe human cell-mediated immune responses to B. pseudomallei and to identify candidate
antigens for vaccine development, the ability of antigen-pulsed monocyte-derived dendritic cells (moDCs) to
trigger autologous T-cell responses to B. pseudomallei and its products was tested. moDCs were prepared from
healthy individuals exposed or not exposed to B. pseudomallei, based on serological evidence. These were pulsed
with heat-killed B. pseudomallei or purified antigens, including ABC transporters (LolC, OppA, and PotF), Bsa
type III secreted proteins (BipD and BopE), tandem repeat sequence-containing proteins (Rp1 and Rp2),
flagellin, and heat shock proteins (Hsp60 and Hsp70), prior to being mixed with autologous T-cell populations.
After pulsing of cells with either heat-killed B. pseudomallei, LolC, or Rp2, coculturing the antigen-pulsed
moDCs with T cells elicited gamma interferon production from CD4 T cells from seropositive donors at levels
greater than those for seronegative donors. These antigens also induced granzyme B (cytotoxic) responses from
CD8 T cells. Activation of antigen-specific CD4 T cells required direct contact with moDCs and was
therefore not dependent on soluble mediators. Rp peptide epitopes recognized by T cells in healthy individuals
were identified. Our study provides valuable novel data on the induction of human cell-mediated immune
responses to B. pseudomallei and its protein antigens that may be exploited in the rational development of
vaccines to combat melioidosis.
Burkholderia pseudomallei is a Gram-negative facultative in-
tracellular bacterium that causes melioidosis, a severe invasive
disease that is endemic in Southeast Asia, Northern Australia,
and several other tropical regions (7, 32). Acute septic melioid-
osis has a high mortality rate in northeast Thailand (approxi-
mately 50%), even in patients who receive appropriate antibi-
otics. Serological evidence based on indirect hemagglutination
assay (IHA) indicates that 80% of people living in areas of
endemicity have been exposed to B. pseudomallei with no clin-
ical symptoms, and the prevalence of positive serology in-
creases with age (4, 9). Recurrent melioidosis can also occur,
either as a relapse after antibiotic treatment or as reinfection
(21). B. pseudomallei is classified as an NIAID category B
potential agent for biological terrorism (24). The mechanisms
by which the organism evades the bactericidal effects of the
host immune response are not fully understood, and there are
no licensed vaccines at the time of this writing.
Recently, we used a B. pseudomallei protein microarray to
identify proteins of the organism recognized by the human
humoral immune system (13). However, development of effec-
tive melioidosis vaccines also requires consideration of the
cell-mediated immune response owing to intracellular per-
sistence of the bacterium. In animal models, the crucial
mediator of resistance to acute B. pseudomallei infection is
gamma interferon (IFN-) produced by multiple cell types,
including NK cells and both CD4 and CD8 T cells (17, 20,
26). T-cell-mediated responses to some recombinant pro-
teins of B. pseudomallei have been studied. Immunization of
mice with a live-attenuated ilvI mutant of B. pseudomallei
(2D2) induced antigen-specific T cells, including CD4 T cells
that respond to proteins secreted by the Bsa type III secretion
system (T3SS) (BopE and BipD) (16). B. pseudomallei 2D2-
primed T cells also recognize bacterial proteins of the ATP-
binding cassette (ABC) family, including LolC, PotF, and
OppA, and respond by producing IFN- (18). In an assay to
evaluate candidate vaccine antigens, immunization of mice
with adjuvant-mixed Bip proteins did not elicit protection
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against B. pseudomallei infection (11, 27). However, antibodies
to BipB, BipC, and BipD have been detected in sera of me-
lioidosis patients (11, 28). Furthermore, a DNA vaccine en-
coding the flagellin protein and carrying CpG motifs enhanced
resistance of immunized mice to B. pseudomallei (5, 6). Owing
to the incomplete protection afforded by candidate antigens to
date, it is necessary to search for additional proteins for vac-
cine development. Tandem repeat (TR) sequence-containing
proteins of B. pseudomallei (such as Rp1 and Rp2) may be
considered vaccine candidates, as proteins containing TRs are
known targets of B-cell responses (15). Heat shock proteins
(HSPs) have also been found to play a role in intracellular
antigen processing, presentation, and cross-presentation (36).
Indeed, a DNA vaccine encoding a Mycobacterium bovis BCG
heat shock protein could enhance T-cell activation against
mycobacterial infection (19). The HSPs of B. pseudomallei
have not been studied for vaccine development to date.
Dendritic cells (DCs) are the control center of the immune
system and are specialized antigen-presenting cells that regu-
late the initiation of T-cell responses to eradicate invading
pathogens (31). In mice, immunization with DCs pulsed with
heat-killed B. pseudomallei in the presence of CpG adjuvant
led to the induction of both cell-mediated and humoral re-
sponses to the organism (12). However, little is known about
the biology of DCs in relation to B. pseudomallei antigens and
the generation of effective T-cell immunity in humans. In a
previous study, we determined the ability of the ABC trans-
porter proteins LolC, OppA, and PotF to restimulate T cells in
whole blood or peripheral blood mononuclear cells (PBMC)
from seropositive healthy humans and recovered melioidosis
patients living in areas where melioidosis is endemic (29). Here
we extended these observations by examining the ability of B.
pseudomallei and a panel of its antigens to pulse human mono-
cyte-derived dendritic cells (moDCs) to stimulate autologous
T-cell populations in vitro.
Our data show that autologous human DCs efficiently pro-
cessed and presented heat-killed B. pseudomallei and its puri-
fied antigens to CD4 T cells and, to a lesser extent, CD8 T
cells, in a contact-dependent manner. Using this approach,
tandem repeat sequence-containing proteins were found to be
novel T-cell immunogens of B. pseudomallei. We provide novel
data on the B. pseudomallei antigens presented by human DCs,
some of which are candidates for inclusion in vaccines to elicit
cell-mediated immunity against melioidosis.
(This work was presented in part at the European Melioid-
osis Network Conference, London, England, 11 September
2009.)
MATERIALS AND METHODS
Human subjects. The consent form for the study was approved by the Khon
Kaen University Ethics Committee for Human Research (project number
HE470506). All subjects signed the consent form, and the data collected were not
disclosed. Leukocyte-rich samples from healthy blood donors were collected as
leftover samples from the Blood Transfusion Center, Faculty of Medicine, Khon
Kaen University. The healthy subjects were divided into either seronegative or
seropositive groups, based on titers of antibody to B. pseudomallei quantified by
IHA. Seronegative subjects were selected on the basis of IHA titers of 1:40,
whereas the seropositive subjects presumed to have been exposed to B.
pseudomallei were selected by titers of 1:40 or greater (8). Both the seronegative
and seropositive donors were age matched and had no clinical history of me-
lioidosis but lived in an area where melioidosis is endemic (predominantly the
northeast region of Thailand).
moDCs. PBMC were isolated by Ficoll-Hypaque density gradient centrifuga-
tion of leukocyte-rich samples. Monocytes (CD14) and CD4 and CD8 T
cells were then isolated by positive selection using immunomagnetic beads
(Miltenyi Biotec, Germany), and their purity was determined by flow cytometry
as described below. Immature DCs were generated from monocytes by culture in
300 U/ml of granulocyte-macrophage colony-stimulating factor (GM-CSF) (Pre-
protech) and 200 U/ml of interleukin-4 (IL-4) (Preprotech) for 6 days in 1 ml of
complete RPMI 1640 (RPMI 1640 containing 10% [vol/vol] heat-inactivated
fetal bovine serum [FBS], 100 U/ml penicillin, 100 g/ml streptomycin, and 2
mM L-glutamine [Sigma-Aldrich]). Every 2 days, 500 l of culture supernatant
was removed, and 500 l of fresh culture medium containing cytokines at the
same final concentrations was added.
Proteins and peptides. LolC, OppA, and PotF polypeptides lacking predicted
membrane-spanning domains were expressed in Escherichia coli under kanamy-
cin selection and purified as previously described (18). Expression and purifica-
tion of BipD and BopE proteins in E. coli have been described elsewhere (16).
The full-length B. pseudomallei Hsp60 (BpHsp60), Hsp70 (BpHsp70), and flagel-
lin (Flg) genes were cloned and expressed in E. coli M15 cells and then purified
as described previously (34). Rp proteins and peptides were synthesized by In
Bios International, Inc. (Seattle, WA). The purity of affinity-tagged recombinant
proteins was evaluated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and their concentration determined using bicinchoninic acid assays
(Pierce Biotechnology). All recombinant B. pseudomallei proteins used in this
study were negative when assayed for the presence of contaminating lipopoly-
saccharide by use of Limulus amebocyte lysate reagent (Pyrotell; Associates of
Cape Cod), with a limit of detection of 0.03 endotoxin unit (EU)/ml.
Coculture of monocyte-derived dendritic cells with T cells. B. pseudomallei
strain K96243 was cultured in Luria-Bertani medium and inactivated by heating
at 100°C for 20 min. The number of viable bacteria prior to heat inactivation was
determined by plating of serial dilutions to permit estimation of the multiplicity
of infection (MOI). moDCs were pulsed with heat-killed B. pseudomallei (MOI
of 10:1) or purified B. pseudomallei proteins (1 g/ml) for 18 h. The pulsed
moDCs were washed twice with phosphate-buffered saline (PBS), plated at 4 
104 cells/well into 96-well plates, and cocultured with autologous CD4 and
CD8 T cells at 4  105 cells/well (ratio of moDCs to T cells  1:10). Culture
supernatants were collected after 48 h of coculture, and IFN- levels were
measured by enzyme-linked immunosorbent assay (ELISA) as described below.
The polyclonal activator phytohemagglutinin (PHA; Biochrom AG, Germany)
served as a positive control for T-cell activation. The IFN--inducing cytokines
interleukin-12 (IL-12) and IL-15 (BD Biosciences) were used as a positive con-
trol for cytokine activation of T cells via the T-cell receptor (TCR)-independent
pathway (29) Cultures of moDCs or T cells alone were used as negative controls.
Transwell assay to demonstrate T-cell activation by pulsed DCs via TCR-
dependent pathway. Transwell chambers consist of an upper and a lower cham-
ber separated by a 0.4-m-pore-size polycarbonate membrane (Corning) that
allows diffusion of cytokines and chemokines through the membrane but avoids
contact interaction of the cells in both chambers. moDCs were pulsed with
heat-killed B. pseudomallei (MOI of 10:1) or purified B. pseudomallei protein
(LolC or Rp2) (1 g/ml) for 18 h as described above. The pulsed moDCs were
washed twice with PBS and plated onto the upper chamber, and autologous
purified CD4 T cells were placed in the lower chamber (DC/CD4 T-cell
ratio  1:10). The cultures were incubated at 37°C in 5% CO2 for 48 h. The
supernatant was collected and kept at 20°C for use in an ELISA to measure
IFN-.
Quantification of IFN- in culture supernatants by ELISA. The supernatants
of moDC–T-cell cocultures were assayed for IFN- production by use of an
ELISA kit (BD Biosciences). Plastic 96-well microtitration plates were coated
with a monoclonal antibody (MAb) to human IFN- in 0.1 M carbonate-bicar-
bonate buffer overnight at 4°C. The excess reagent was removed by washing the
plate three times with 0.005% (vol/vol) Tween 20 in PBS, and the plate was then
blocked with 10% (vol/vol) fetal calf serum (FCS) in PBS and incubated for 1 h.
The plate was washed three times, and then test supernatants or a recombinant
human IFN- standard was added and incubated for 2 h at room temperature
(RT). After washing of the plate, biotinylated anti-human IFN- and avidin-
horseradish peroxidase conjugate were added and incubated for 1 h at RT. The
plate was washed seven times, and then a substrate solution was added and
incubated for 30 min at RT in the dark. Reactions were stopped with 2 N H2SO4,
and absorbance was read at 450 nm with an ELISA plate reader (Tecan, Aus-
tria).
Quantification of cells secreting IFN- and GrB. CD4 and CD8 T cells
producing IFN- or granzyme B (GrB) were enumerated by enzyme-linked
immunospot (ELISPOT) assay. In summary, precoated 96-well polyvinylidene
difluoride (PVDF) plates (MSIP; Millipore) were incubated overnight with 15
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g/ml of IFN-- or GrB-specific antibody, and then 4  104 moDCs pulsed with
heat-killed B. pseudomallei or purified B. pseudomallei proteins were added to
the plate in duplicates. Pulsed moDCs were then cocultured with autologous
CD4 or CD8 T cells for 48 h, and IFN- and GrB secretion was detected by
addition of 1 g/ml biotinylated anti-human IFN- and GrB at room tempera-
ture for 3 h. After washing of the plate, 1 g/ml streptavidin-alkaline phos-
phatase was added for 1 h, and spots were revealed with a Bio-Rad alkaline
phosphatase kit and enumerated under a stereomicroscope.
Flow cytometric analysis. Purities of CD14, CD4, and CD8 cells after
separation by use of immunomagnetic beads were determined by flow cytometry
after surface marker staining with fluorescein isothiocyanate (FITC)-conjugated
marker-specific antibodies (Becton Dickinson) at a concentration of 0.06 to 1
g/1 106 cells. Monocytes differentiated into DCs were enumerated by staining
of DC-associated surface markers (CD11c and HLA-DR) and decreased ex-
pression of CD14, using 0.06 to 1 g/1  106 cells of FITC–anti-CD14, FITC–
anti-CD11c, and phycoerythrin (PE)–anti-HLA-DR. Flow cytometry was used
for the characterization of IFN--producing memory CD4 T cells, using allo-
phycocyanin (APC)–anti-IFN-, FITC–anti-CCR7, and PE–anti-CD45RA. Iso-
type-matched controls were included in each analysis. Staining of immune cell
surface markers was performed for 30 min at 4°C. Data acquisition was per-
formed with a Becton Dickinson FACSCalibur instrument and analyzed by
CellQuest software (BD Biosciences). Forward scatter/side scatter was used as
the first gate, with selection of lymphocytes in the first gate, followed by an IFN-
dot plot for analysis of IFN- cell frequency, with fast acquisition, at 1,500
total events/second. Following flow cytometry analysis, the purity of each cell
type was over 96%. The memory T-cell subsets were identified by gating on
IFN- cells, and then combined analysis of CCR7 and CD45RA was used to
characterize central memory T cells (TCM; CCR7 CD45RA), effector memory
T cells (TEM; CCR7 CD45RA), effector memory RA T cells (TEMRA; CCR7
CD45RA), and resting T cells (CCR7 CD45RA).
MHC class II epitope prediction. Epitope prediction programs, including the
Immune Epitope Database (IEDB) (http://tools.immuneepitope.org/analyze
/html/mhc_II_binding.html) and ProPred (http://www.imtech.res.in/raghava
/propred/), were used to predict dominant human Th1-cell epitopes of the full-
length Rp amino acid sequences in relation to major histocompatibility complex
(MHC) class II restriction (10-mers to 15-mers, depending on the program used).
Predicted epitopes that ranked highly across both programs were selected for
further evaluation. Preference was given to epitopes that showed high hypothet-
ical affinities for more than one HLA type.
In vitro stimulation of human PBMC with B. pseudomallei Rp peptides. PBMC
from healthy donors living in an area of melioidosis endemicity were isolated
from buffy coat samples by density centrifugation on Histopaque 1077 (Sigma-
Aldrich), and the number of cells was adjusted as required prior to stimulation.
The isolated PBMC were stimulated with PHA as a mitogen, with 1 g/ml LolC
as a positive antigen control, with 3 g/ml Rp proteins or peptides, or with
medium alone as a negative control. Peptides 1 to 7 were test peptides derived
from B. pseudomallei Rp proteins. The number of cells stimulated to secrete
IFN- was evaluated by ELISPOT assay as described above.
HLA typing. HLA-DRB1 alleles in the samples used above were determined
by PCR sequence-specific primer (PCR-SSP), using 20 pairs of primers (22, 23).
The primer mixtures contained a pair of allele-specific primers and a pair of
256-bp internal control primers.
Statistical analysis. Statistical analysis (Mann-Whitney test) was performed
using Graphpad Prism software, version 5 (GraphPad, San Diego, CA). A P
value of 0.05 was considered statistically significant.
RESULTS
T-cell responses of seropositive versus seronegative healthy
donors to moDCs pulsed with heat-killed B. pseudomallei. We
demonstrated previously, using a whole-blood assay, that T
cells from seropositive and recovered melioidosis subjects re-
spond to heat-killed B. pseudomallei by producing IFN- (29).
Here we first defined the contributions of IFN- production
from CD4 and CD8 T cells cocultured with antigen-pulsed
autologous moDCs. T-cell subsets were purified from 9 healthy
donors who were seropositive for B. pseudomallei and from 8
seronegative donors. These were cocultured with heat-killed B.
pseudomallei-pulsed moDCs for 48 h, and then the IFN- lev-
els in cultured supernatants were assayed by ELISA. The ratio
of moDCs to T cells was optimized by comparing responses to
heat-killed B. pseudomallei at ratios of 1:5, 1:10, 1:50, and
1:100, with the highest IFN- level being observed at a moDC/
T-cell ratio of 1:10. Moreover, the incubation period and the
concentration of each protein were also optimized (data not
shown). Cells were stimulated separately with PHA and me-
dium alone, as positive and negative controls, respectively.
CD4 T cells of 6/8 seronegative donors showed statistically
significant IFN- responses to heat-killed B. pseudomallei com-
pared with the medium control, but the magnitude of IFN-
secretion was low (Fig. 1). In contrast, 8 of 9 seropositive
donors showed extensive IFN- production, with a mean value
of 10.52 ng/ml, compared to 0.81 ng/ml for the seronegative
group (P  0.001). A response by CD8 T cells from 7/9
seropositive donors was also observed but was 13-fold lower
than the CD4 T-cell response, showing that the latter were
the dominant IFN--producing T cells under these restimula-
tion conditions (P  0.001; Mann-Whitney test). These results
are consistent with previous data from whole-blood assays (29).
Purified B. pseudomallei proteins are recognized by CD4 T
cells of seropositive healthy donors. In an effort to identify the
proteins of B. pseudomallei recognized by cell-mediated immu-
nity in humans, the IFN- responses of CD4 T cells to 10
different purified Bps proteins presented by moDCs were eval-
uated. The proteins, namely, LolC, OppA, and PotF (ABC
transporter proteins), BipD and BopE (Bsa T3SS proteins),
Hsp60 and Hsp70 (heat shock proteins), Rp1 and Rp2 (tan-
dem repeat-containing proteins), and flagellin, were expressed
in E. coli and affinity purified as described in Materials and
Methods. moDCs from 9 seropositive and 8 seronegative
healthy donors were pulsed separately with each purified pro-
tein for 48 h. PHA and heat-killed B. pseudomallei served as
positive controls owing to their ability to evoke strong re-
sponses of CD4 T cells from seropositive donors (Fig. 1),
while negative controls were comprised of medium, moDCs
FIG. 1. IFN- production by T-cell subsets from seropositive com-
pared to seronegative healthy donors in response to moDCs pulsed
with heat-killed B. pseudomallei (HkBp). Monocyte-derived DCs were
pulsed with heat-killed B. pseudomallei or medium for 18 h and then
cocultured with autologous CD4 and CD8 T cells (ratio of moDCs
to T cells of 1:10). PHA-stimulated T cells were used as a positive
control. Culture supernatants were collected at 48 h, and IFN- levels
were measured by ELISA. The controls included medium as a negative
control and PHA as a positive control for mitogen stimulation. ***,
P  0.001 by Mann-Whitney test between IFN- production of autol-
ogous CD4 T cells in response to heat-killed B. pseudomallei-pulsed
moDCs from seropositive (n 9) and seronegative (n 8) donors and
between IFN- production of autologous CD4 T cells and CD8 T
cells in response to heat-killed B. pseudomallei-pulsed moDCs from
seropositive donors.
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alone, and unstimulated CD4 T cells (Fig. 2A). The results
for the B. pseudomallei protein LolC showed that 4 of 7 sero-
positive individuals had a modest response to LolC, 3 had a
response that was higher than the average, and 1 had a strong
response; a similar response was observed with the Rp2 pro-
tein. The mean quantities of IFN- produced by CD4 T cells
from seropositive donors in response to LolC and Rp2 were
higher than those for the seronegative group (Fig. 2B) (P 
0.01 and P  0.05, respectively). The other proteins also elic-
ited elevated levels of IFN- from some, but not all, individuals
in the seropositive group (3/9 seropositive donors), but this
heterogeneity resulted in no statistically significant differences
when the means between seropositive and seronegative donors
were compared. Notably, CD4 T cells from these 3 seropos-
itive donors responded strongly to all 10 B. pseudomallei pro-
teins, while the other 6 individuals were low responders.
Heat-killed B. pseudomallei and its proteins are recognized
by effector memory CD4 T cells through a contact-dependent
pathway. The previous result indicated the dominant response
of CD4 T cells of seropositive healthy donors to heat-killed B.
pseudomallei and the B. pseudomallei proteins LolC and Rp2.
We previously demonstrated that production of IFN- by T
cells in response to B. pseudomallei occurs predominately via
T-cell receptors but can also occur via a cytokine-dependent,
cyclosporine A-insensitive pathway (20, 29). To investigate
whether the stimulation of CD4 T cells by pulsed moDCs
observed here occurred via the T-cell receptor pathway, a
Transwell culture method was used to prevent cell-to-cell con-
tact but permit diffusion of soluble factors during coculture.
moDCs from seropositive healthy donors were pulsed sepa-
rately with heat-killed B. pseudomallei or recombinant LolC or
Rp2, plated into 24-well culture plates, and incubated for 18 h.
Autologous purified CD4 T cells were then plated on a poly-
carbonate insert well at a moDC/CD4 T-cell ratio of 1:10 and
cocultured for 48 h, and the IFN- concentration in culture
supernatants was measured by ELISA. The amount of IFN-
produced by CD4 T cells cocultured with but separated from
moDCs pulsed with heat-killed B. pseudomallei, LolC, or Rp2
was reduced to the baseline level compared to cocultures in
direct contact (Fig. 3A) (P 0.05). This indicates that antigen-
pulsed moDCs stimulate CD4 T cells to produce IFN- pre-
dominantly through a contact-dependent pathway rather than
as a consequence of bystander cytokine-mediated effects.
To identify IFN--producing CD4 T-cell subsets, memory
phenotypes of T cells were characterized. Our previous study
classified T-cell phenotypes based on expression of CD45RA
and CCR7, whereby CD45RA CCR7 denotes naive or rest-
ing T cells, CD45RA CCR7 denotes TCM (central memory)
cells, CD45RA CCR7 denotes TEM (effector memory) cells,
and CD45RA CCR7 denotes TEMRA (terminally differen-
tiated effector memory RA) cells (2). In this study, purified
CD4 T cells from seropositive donors were cocultured with
moDCs primed separately with heat-killed B. pseudomallei or
LolC for 24 h, and IFN--producing CD4 T cells were ana-
lyzed by flow cytometry. The results showed that the majority
of IFN--producing CD4 T cells cocultured with moDC-
pulsed heat-killed B. pseudomallei or LolC were TEM cells
(76% and 73% of IFN--producing CD4 T cells, respec-
FIG. 2. IFN- production of CD4 T cells from seropositive versus seronegative healthy donors in response to purified B. pseudomallei
proteins. The moDCs of seropositive and seronegative healthy donors were pulsed with heat-killed B. pseudomallei or its proteins for 18 h
and then cocultured with CD4 T cells. Culture supernatants were collected at 48 h, and IFN- levels in culture supernatants were measured
by ELISA. (A) The negative-control set consisted of moDCs plus T cells, moDCs alone, and T cells alone that were cultured in medium.
Positive controls included mitogen (PHA) and heat-killed B. pseudomallei. (B) Responses to purified proteins. **, P  0.01; *, P  0.05 (by
Mann-Whitney test between IFN- production of autologous CD4 T cells in response to antigen-pulsed moDCs from seropositive and
seronegative donors).
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tively). The other CD4 T-cell phenotypes detected in re-
sponse to moDCs pulsed with heat-killed B. pseudomallei and
LolC were 9% and 4% TCM cells, 11% and 16% TEMRA cells,
and 4% and 7% resting T cells, respectively (Fig. 3B). Thus, in
healthy seropositive donors, effector memory CD4 T cells are
the major contributors to the IFN- response under these
culture conditions.
Heat-killed B. pseudomallei and its purified proteins activate
cytotoxic CD8 T cells to produce GrB. GrB is a serine pro-
tease that is an important mediator of target cell apoptosis by
cells such as natural killer cells and cytotoxic CD8 T cells
(25). To evaluate whether moDCs pulsed with heat-killed B.
pseudomallei or purified proteins can stimulate B. pseudomal-
lei-specific cytotoxic T lymphocytes (CTLs), we measured the
expression of GrB in CD8 T cells from seropositive subjects
in response to moDCs pulsed separately with heat-killed B.
pseudomallei or the 10 B. pseudomallei proteins described
above. The number of cells producing GrB was evaluated by
ELISPOT assay. The results revealed that moDCs pulsed with
heat-killed B. pseudomallei, LolC, and Hsp60 could activate
CD8 T cells to produce GrB (Fig. 4). The other B. pseudoma-
llei proteins tended to stimulate CD8 T cells of certain sero-
positive subjects even though GrB secretion was not signifi-
cantly different from that with the medium negative control.
Thus, of the 10 antigens tested, only LolC was recognized by
both reactive CD4 T cells and CD8 T cells.
Prediction of T-cell epitopes of B. pseudomallei tandem re-
peat sequence-containing proteins (Rp proteins). Our data
indicate that B. pseudomallei Rp2 significantly stimulates T-cell
responses when presented by moDCs (Fig. 2). It was therefore
of interest to identify the immunodominant epitopes of Rp
proteins. Seven peptides were analyzed for their hypothetical
strength of binding and range of affinity (Table 1). It was
predicted that peptides 1, 2, 5, and 6 would be recognized most
efficiently by HLA-DR04. Peptide 5 was predicted to be rec-
ognized by HLA-DR03, -DR04, -DR11, and -DR15. Peptide 7
would be recognized by HLA-DR13 according to ProPred
prediction, but it would not be recognized by any HLA-DR
according to IEDB prediction. Peptides 3 and 4 were predicted
not to be bound by any type of HLA-DR; however, they may be
recognized by other MHC class II molecules.
Rp peptides elicit responses from PBMC of healthy donors
from an area where melioidosis is endemic. To investigate the
immune response to Rp proteins and its peptides in healthy
individuals in an area where melioidosis is endemic, PBMC
from 6 volunteers were stimulated separately with LolC, Rp
proteins, and the 7 Rp peptides predicted above (peptides 1 to
7). IFN- production was then measured by ELISPOT assay.
The IFN- responses to both Rp1 and Rp2 were statistically
significant; moreover, significantly greater numbers of cells
responded to peptides 1, 3, 4, 5, and 6 than to the medium
control (Fig. 5). To map the T-cell epitopes recognized by
healthy subjects, typing of HLA-DRB1 was performed for all
donors. HLA-DR typing of the donors responding to the pep-
tides demonstrated that they represented a heterogeneous
group with respect to HLA, expressing DR15,12, DR13,07,
FIG. 3. IFN- response of CD4 T cells from exposed healthy donors to heat-killed B. pseudomallei- or purified B. pseudomallei protein-pulsed
moDCs requires cell contact. (A) CD4 T cells isolated from seropositive healthy donors were cocultured with moDCs pulsed with heat-killed B.
pseudomallei, LolC, or Rp2 in the presence (white bars) or absence (black bars) of polycarbonate insert wells to separate moDCs from T cells. The
culture supernatants were collected, and IFN- levels were measured by ELISA. (B) Phenotypic flow cytometry analysis of intracellular
IFN--producing CD4 T cells from a single seropositive healthy donor in response to moDCs pulsed with heat-killed B. pseudomallei and LolC.
CD4 T cells were stained with APC–anti-IFN-, FITC–anti-CCR7, and PE–anti-CD45RA prior to analysis by gating on lymphocyte cells (first
row) and IFN- cells (second row). Isotype-matched controls were also included in the analysis (third row).
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DR15,14, DR15,04, DR03,04, and DR04,10 (Table 2). The
ability of donor PMBC to respond to Rp peptides was largely
consistent with the computational prediction of HLA-re-
stricted epitopes, whereby peptides 1, 2, 5, 6, and 7 were pre-
dicted to bind HLA-DR types (Table 1).
DISCUSSION
B. pseudomallei causes severe invasive infections with a high
mortality rate in areas where melioidosis is endemic. Recent
studies have begun to unravel the bacterial constituents and
host responses required for control of melioidosis. For exam-
ple, we identified protein targets of human antibody responses
by using protein microarrays (13). However, the development
of effective vaccines for B. pseudomallei likely requires cell-
mediated immunity owing to the ability of the pathogen to
persist for protracted periods in an intracellular niche. In a
previous study, we applied a whole-blood assay to explore
human cellular responses to the pathogen, demonstrating the
priming of B. pseudomallei-reactive T cells in healthy individ-
uals living in the region of endemicity of northeast Thailand.
However, such assays do not examine the antigen-presenting
cell–T-cell interactions required for successful immune re-
sponses and give high background levels of IFN- due to the
FIG. 4. Granzyme B production from purified CD8 T cells in response to moDCs pulsed with heat-killed B. pseudomallei or recombinant
proteins. moDCs were pulsed with heat-killed B. pseudomallei or recombinant proteins for 18 h and then cocultured for 48 h with CD8 T cells
(ratio of moDCs to T cells of 1:10), and GrB-producing cells were enumerated by ELISPOT assay. (A) Numbers of GrB-producing CD8 T cells
with medium alone or in the presence of IL-12 and IL-15. (B) Numbers of GrB-producing CD8 T cells in response to heat-killed B. pseudomallei
or 10 purified proteins. SFC, spot-forming cells. *, P  0.05 by Mann-Whitney test between GrB secretion of autologous CD8
 T cells in response
to antigen-pulsed moDCs and that for the medium negative control (moDCs plus T cells) in the same panel.
TABLE 1. HLA-DR-restricted epitopes of B. pseudomallei Rp proteins, predicted by IEDB and ProPred
Peptide no. Sequence IEDBa ProPredb HLA-DR restriction
1 SGVASNAVGTLTNLANNNPL 5.42 39.36 DR04
2 PGALSNAVGTLQNAATNNPL 3.56 26.6 DR04
3 SGTSSTATGQGSQATGSNSTATGQDATA
4 SGESSTAMGQGSQATGNNSTATGQDATA
5 STSVVGISISFTGISVSYTGLSVSFTGV 3.21, 4.25, 5.96, 8.65 41.05, 30, 38.46, 31.12 DR03, -04, -11, -15
6 SASFTGLSTSFTGVSTSFTGVSTSFTGV 3.87 24.44 DR04
7 AAAEAAAAQAVTDKTAAEALAMQAAAER 28.41 DR13
a Lower scores predict stronger affinities for respective HLA types.
b The higher the prediction rank, the higher the hypothetical affinity for each HLA type.
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presence of NK cells (29). In an effort to circumvent these
issues, heat-killed bacteria and 10 purified proteins of the
pathogen were evaluated for the ability to stimulate T-cell
responses when presented by autologous moDCs.
DCs are professional antigen-presenting cells and play a
central role in initiating T-cell responses. Evidence exists that
B. pseudomallei-infected human moDCs are able to induce
T-cell differentiation toward a Th1 population in a manner
dependent upon cytokine production (3). Our study revealed
that moDCs pulsed with heat-killed B. pseudomallei or recom-
binant protein antigens stimulated IFN- production predom-
inantly by CD4 T cells rather than by CD8 T cells ex vivo.
After heat-killed B. pseudomallei stimulation, IFN--producing
cells from seropositive subjects responded to a much greater
extent than did those from seronegative subjects from the area
of endemicity. In seropositive donors, IFN- production from
CD4 T cells was considerably higher than that from CD8 T
cells. This result is consistent with previous data showing that
induction of IFN- in response to the organism is elevated in
seropositive donors (1, 29).
The important role of CD4 T cells has been demonstrated
in a mouse model of melioidosis, where antigen-specific CD4
T cells were induced by infection with a live-attenuated B.
pseudomallei mutant and correlated with protection against
secondary infection (16, 17). The role of CD4 T cells in
human melioidosis is less clear, since HIV/AIDS is apparently
not a risk factor for melioidosis (10). Nevertheless, our findings
confirm that exposure to B. pseudomallei clearly results in
priming of a robust T-cell response, as CD4 T cells from
seropositive individuals responded to moDCs pulsed with heat-
killed B. pseudomallei by producing high levels of IFN-. This
was consistent with our previous study of whole-blood cultures
that revealed an association between the secretion of IFN-
from antigen-specific T cells in response to the pathogen or its
ABC transporter proteins (LolC, OppA, and PotF) and in-
creasing antibody titers (29). To further identify antigens that
may be involved in this process, we confirmed the immunoge-
nicity of ABC transporter proteins and screened new purified
proteins, some of which are associated with B. pseudomallei
virulence, for the ability to stimulate human T cells when
presented by moDCs. This revealed that the newly defined
Rp2 protein elicited significantly higher IFN- responses in
primed CD4 T cells than in controls.
In addition, CD4 T cells of some responders from the
seropositive group could produce IFN- at levels above the
mean in response to the other proteins tested, including ABC
FIG. 5. Identification of immunogenic epitopes of B. pseudomallei Rp protein. PBMC were separated from leukocyte-rich samples from 6
donors. PBMC (5  105 cells/ml) were incubated with each stimulator for 42 h. (A) The controls included medium as a negative control, PHA as
a mitogen positive control, and LolC as an antigen-specific control. (B) Rp proteins (Rp1 and Rp2) and seven Rp peptides were used as antigen
stimulators. IFN--secreting cells were enumerated under a stereomicroscope. Each horizontal line denotes the mean, and error bars show the
standard error of the mean. *, P  0.05; **, P  0.01; ***, P  0.001; NS, not significant (by Mann-Whitney test between IFN- spot-forming
cells of individual antigen proteins/peptides and the medium control).
TABLE 2. Antigen-induced secretion of IFN- from PBMC of healthy donors in response to Rp peptides of B. pseudomallei,
according to HLA class II allele
Donor IHA titer APC
No. of spot-forming cells secreting IFN-/106 PBMC in response to peptidea
1 2 3 4 5 6 7
EM026 1:10 HLA-DR12,15 69 83 96 97 98 73 39
EM029 1:40 HLA-DR07,13 86 112 100 132 159 116 98
EM031 1:320 HLA-DR14,15 174 144 120 146 139 140 50
EM032 1:80 HLA-DR04,15 77 57 127 117 109 75 46
EM033 1:40 HLA-DR03,04 34 25 44 74 79 48 90
EM034 1:40 HLA-DR04,10 99 98 110 228 140 160 40
a In the IFN- assay, a response was considered positive when the IFN- concentration in the culture stimulated with peptide was equal to or higher than the mean
 2 standard deviations for the medium control, comprising 100 spot-forming cells/106 PBMC. Statistically significant responses are indicated in bold.
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transporter proteins (OppA and PotF), T3SS proteins (BipD
and BopE), heat shock proteins (Hsp60 and Hsp70), the tan-
dem repeat protein Rp1, and flagellin. These results suggested
that there were 2 groups of seropositive individuals, those who
were relatively high and low responders to B. pseudomallei.
Meanwhile, CD4 T cells reactive to purified BipD and BopE
have been detected following immunization of mice; however,
in murine models, immunization with BipD or other predicted
components of the Bsa type III secretion apparatus has not
elicited significant protection against acute melioidosis (11,
27). Conversely, recombinant flagellin could provide limited
protection in mice, albeit not as great as that when the protein
was given as a plasmid DNA vaccine or with specific adjuvants
such as CpG (5, 6, 30). Recombinant Hsp, especially Hsp70,
can induce T-cell responses due to flagellin contamination
(34). It remains possible that other T3SS-, flagellum-, or Hsp-
related proteins may induce protective human cell-mediated
immunity or that responses to existing antigens characterized
to date may be improved rationally by using novel delivery or
adjuvant strategies.
In a whole-blood assay, NK cells, CD4 T cells, and CD8
T cells from subjects exposed to B. pseudomallei respond to
heat-killed B. pseudomallei by rapidly producing IFN- (29). In
such assays, it is possible that the response could be cytokine
dependent and independent of the TCR pathway. By using a
Transwell system to prevent cell contact but permit diffusion of
soluble mediators, we observed that the dominant response of
the CD4 T-cell subset from exposed subjects to moDCs
pulsed with heat-killed B. pseudomallei, LolC, or Rp2 relies on
a cell-to-cell contact-dependent pathway.
Selected components of ABC transport systems, especially
LolC, have been demonstrated to induce partial protection
when mixed with adjuvant and used to immunize mice (18) as
well as to induce human antigen-specific T-cell responses (29).
Proteins of the tandem repeat family, of which Rp2 is a mem-
ber, have been examined as a target for B cells to produce
antibody in certain parasitic infections (15). We show here, for
the first time, that Rp2 elicits human antigen-specific CD4
T-cell responses at least as effectively as LolC, and it will be of
interest to determine if it is similarly effective in inducing
partial protection against melioidosis in mice.
We used differential expression of CD45RA and CCR7 to
characterize the IFN--producing CD4 T cells as central
memory, effector memory, and the more recently described
effector memory RA populations (2). By these criteria, the
majority of IFN- CD4 T cells reacting to heat-killed B.
pseudomallei and LolC were found to be TEM cells (76% and
73%, respectively), with the remaining minority being TEMRA
and TCM cells. While TCM cells potentially could provide a
rapid function by producing cytokines that aid in the genera-
tion of TEMRA cells (14, 33), it is likely that the whole-blood
assay involves distinct T-cell interactions from those detected
with antigen-pulsed moDCs.
Although CD4 T cells were the dominant producers of
IFN- in these assays, heat-killed bacteria and B. pseudomallei
Hsp60 were also able to stimulate CD8 T cells to secrete
granzyme B, an indicator of potential cytotoxic activity. In
mycobacterial infections, immunization with mycobacterial
Hsp60 induced the cytotoxic function of CD8 T cells specific
for mycobacterial Hsp60 (35).
Having provided the first evidence that the B. pseudomallei
Rp2 protein is a target of human cell-mediated responses, we
sought to identify Rp peptide epitopes and determine if they
were recognized by coculture with PBMC of healthy donors of
various HLA types living in northeast Thailand. Five of seven
predicted MHC class II epitopes of Rp stimulated a significant
number of IFN--secreting cells. HLA typing of individuals
revealed that 50% of subjects presented heterozygous alleles of
HLA-DR04 and 50% of subjects presented heterozygous al-
leles of HLA-DR15. The most common alleles in the north-
eastern Thai population include DRB1*1202 and DRB1*1502
(23). Our results indicate that several Rp epitopes elicit strong
IFN- responses from human cellular immunity across individ-
uals with HLA-DR-restricted alleles in this small sample of the
Thai population in an area where Burkholderia is endemic.
In conclusion, we evaluated the ability of moDCs pulsed
separately with 10 virulence-associated recombinant proteins
of B. pseudomallei to stimulate autologous human CD4 T-cell
and CD8 T-cell responses. Our results demonstrate that an-
tigen-specific CD4 T cells are generated following exposure
of humans to B. pseudomallei in the environment, as they can
be stimulated to produce IFN- after encountering moDCs
pulsed with heat-killed B. pseudomallei or purified proteins,
particularly LolC and Rp2. Antigen-specific CD8 T cells are
also produced that are a potential source of IFN- and GrB,
especially in response to LolC. Our ability to detect human
antigen-specific T-cell responses to defined B. pseudomallei
proteins informs the selection of candidates for inclusion in
protein or protein-polysaccharide conjugate subunit vaccines
against this important and emerging infection. Moreover, the
Rp epitope sequences analyzed here are conserved across B.
pseudomallei, Burkholderia thailandensis, and the causative
agent of equine glanders, Burkholderia mallei, suggesting that
they would have broad vaccine potential for both human and
veterinary use for melioidosis and glanders.
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